These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28722301)

  • 21. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors.
    Di Pizio A; Laghezza A; Tortorella P; Agamennone M
    ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors.
    Laghezza A; Luisi G; Caradonna A; Di Pizio A; Piemontese L; Loiodice F; Agamennone M; Tortorella P
    Bioorg Med Chem; 2020 Feb; 28(3):115257. PubMed ID: 31874775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review.
    Mehana EE; Khafaga AF; El-Blehi SS
    Life Sci; 2019 Oct; 234():116786. PubMed ID: 31445934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis.
    Bendele AM; Neelagiri M; Neelagiri V; Sucholeiki I
    Eur J Med Chem; 2021 Nov; 224():113666. PubMed ID: 34245949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.
    Kalva S; Vinod D; Saleena LM
    J Mol Model; 2014 May; 20(5):2191. PubMed ID: 24756550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor.
    Senn N; Ott M; Lanz J; Riedl R
    J Med Chem; 2017 Dec; 60(23):9585-9598. PubMed ID: 28953404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
    Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
    Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.
    Fischer T; Riedl R
    Int J Mol Sci; 2016 Mar; 17(3):314. PubMed ID: 26938528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Non-Zinc Binding Inhibitors of MMP-2 Through Virtual Screening and Subsequent Rescoring.
    Shamsara J
    Drug Res (Stuttg); 2018 Sep; 68(9):529-535. PubMed ID: 29614516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy.
    Marques SM; Abate CC; Chaves S; Marques F; Santos I; Nuti E; Rossello A; Santos MA
    J Inorg Biochem; 2013 Oct; 127():188-202. PubMed ID: 23597851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
    Adhikari N; Mukherjee A; Saha A; Jha T
    Eur J Med Chem; 2017 Mar; 129():72-109. PubMed ID: 28219048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.
    Spicer TP; Jiang J; Taylor AB; Choi JY; Hart PJ; Roush WR; Fields GB; Hodder PS; Minond D
    J Med Chem; 2014 Nov; 57(22):9598-611. PubMed ID: 25330343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.
    Tommasi RA; Weiler S; McQuire LW; Rogel O; Chambers M; Clark K; Doughty J; Fang J; Ganu V; Grob J; Goldberg R; Goldstein R; Lavoie S; Kulathila R; Macchia W; Melton R; Springer C; Walker M; Zhang J; Zhu L; Shultz M
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6440-5. PubMed ID: 21937229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis.
    Roy HS; Murugesan P; Kulkarni C; Arora M; Nagar GK; Guha R; Chattopadhyay N; Ghosh D
    J Mater Chem B; 2024 Jun; 12(22):5325-5338. PubMed ID: 38669084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydantoin based inhibitors of MMP13--discovery of AZD6605.
    De Savi C; Waterson D; Pape A; Lamont S; Hadley E; Mills M; Page KM; Bowyer J; Maciewicz RA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4705-12. PubMed ID: 23810497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginsenoside Rb1 inhibits matrix metalloproteinase 13 through down-regulating Notch signaling pathway in osteoarthritis.
    Wang W; Zeng L; Wang ZM; Zhang S; Rong XF; Li RH
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1614-21. PubMed ID: 26062798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.